Détail de l'auteur
Auteur M. GARAU |
Documents disponibles écrits par cet auteur (4)
Ajouter le résultat dans votre panier
Visionner les documents numériques
Faire une suggestion Affiner la recherche
Document de travail
This paper examines the potentially positive impact of differential pricing in Europe and the overall negative effects of international reference pricing (IRP) measures. The authors point out that IRP actually encourages higher prices in lower-i[...]Ouvrage
C. LE PEN ; J.M. GRAF VON SCHULENBURG ; M. GARAU ; A. TOWSE ; L. GARATTINI ; J. COSTA-FONT ; P. DANZON ; M. GARAU, Editeur commercial ; J. MESTRE-FERRANDIZ, Editeur commercial ; Office of Health Economics. (O.H.E.). Londres. GBR, Editeur commercial | Londres : Radcliffe Publishing | 2006Based on a seminar held in November 2005, this book discusses recent developments in pricing and reimbursement within five major European Pharmaceutical markets. Each chapter gives an overview of the current market, including aims, effectiveness[...]Chapitre
C. LE PEN ; M. GARAU, Editeur commercial ; J. MESTRE-FERRANDIZ, Editeur commercial ; Office of Health Economics. (O.H.E.). Londres. GBR, Editeur commercial | Londres : Radcliffe Publishing | 2006Based on a seminar held in November 2005, this book discusses recent developments in pricing and reimbursement within five major European Pharmaceutical markets. This chapter gives an overview of the current market, including aims, effectiveness[...]Bulletin : Fascicule
OHE BRIEFING, 52 - 01/10/2009 - Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries
This study compares the pricing and reimbursement (P&R) arrangements implemented in selected EU countries to make coverage decisions on orphan medicinal products (OMPs) and investigates whether these measures have had an impact on their availabi[...]